Navigation Links
VARI researcher chosen for highly competitive Scholar-in-Training Award
Date:5/1/2009

Grand Rapids, Mich. (April 30, 2009) Van Andel Research Institute (VARI) Research Scientist Jindong Chen, Ph.D., was recently awarded the AACR-Sanofi-Aventis Scholar-in-Training Award for research submitted for presentation at the American Association for Cancer Research (AACR) 100th Annual Meeting.

Chen, a researcher in VARI's Laboratory of Cancer Genetics, presented the findings of his research at the meeting held in Denver from April 18-22, where nearly 17,000 scientists from around the world gathered. This year's AACR meeting featured 6,000 research abstracts for presentation, including cutting-edge breakthroughs in molecular targeting, translational cancer research, and cancer prevention.

With Scholar-in-Training Awards presented to fewer than 10% of applicants, the process is highly competitive. The award was Chen's second. He also received the award in 2003 for cloning two cancer-related genes.

"The AACR is the oldest and largest scientific organization in the world dedicated solely to cancer research," said VARI President and Research Director Dr. Jeffrey Trent. "Research presented at the conference represents the latest and highest achievements in cancer research and reaches an audience of thousands of the world's top scientists."

Chen's research, entitled Proximal tubule-specific knockout of BHD in mouse kidney causes multicystic kidney disease and renal cancer pertains to a cancer called Birt-Hogg-Dub ( BHD) syndrome that affects the skin and lungs and increases the risk of certain types of tumors, including kidney tumors. VARI researchers tested the effect of the BHD gene in two different tubules that are part of the filtration system of the kidney and found initial evidence that one of the tubules may be where BHD originates.

In addition to Chen, five other VARI researchers also delivered oral and/or poster presentations at the conference. They include: Senior Scientific Investigator Art Alberts, P
'/>"/>

Contact: Joe Gavan
616-234-5390
Van Andel Research Institute
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Cancer-obesity link discovery by MSU researchers could aid prevention efforts
2. K-State Researcher Finds That the 1918 Spanish Flu Virus Can Infect Swine and Resulted in Current Lineage of H1N1 Swine Influenza Viruses
3. Researchers design unique method to induce immunity to certain STDs
4. Researchers to Monitor Public Perception of Swine Flu Outbreaks Using Technology from Realtime Search Engine, OneRiot
5. Bio-Matrix Scientific Group and Entest BioMedical Sign Contract With UCLA Researcher to Develop Gestational Diabetes Screening Test
6. Researchers identify stroke predictors in black patients
7. Penn Medicine, CHOP researchers demonstrate first common genetic risk factors for autism
8. FSU researcher wins $2.2 million grant to study childhood obesity
9. Four legendary LA BioMed physician-researchers honored
10. Mayo Clinic researcher says improved detection of bladder tumors reduces cancer recurrence
11. Researchers find drug that inhibits acute leukemia cell growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
(Date:12/4/2009)Outcomes same whether procedure done immediately or 3 weeks later, study shows , , FRIDAY, Dec. 4 (HealthDay News) -- Timing of surgical repair or reconstruction of multiple-ligament knee inju
Breaking Medicine News(10 mins):Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2
...duces personality types used frequently in consume...e are motivated by one of two fundamental needs: t... that will help them achieve hopes and aspirations... exercise self-control when they choose goal-pursu...
...ervice to Retail Markets, MUNDELEIN, Ill., Jan. 2...day the retail launch of its headline-making,salad...e will consist of Z Trim Ranch, Z,Trim Honey Dijon...ht to transfer some of our success from Z,Trim pro...
...special needs child, Chelle Brewer,s, story of tri...spouse alpha moms worl...ewer,s soldier,husband is nearing the end of a hal...a heart. She volunteers for the,USO, Soldier,s Lis...
...s that seem to influence outcome , , WEDNE...ns that predict patient response to the two common...a) and venlafaxine (Effexor) have been identified ...protein called P-gp, which removes drugs and other...
...ap or press a surface is essential for everyday li...y or an iPhone. But researchers at the University...ivial action is the result of a complex neuro-moto...omedical engineer Francisco Valero-Cuevas is worki...
...ef, researchers say , , WEDNESDAY, Jan. 23... back pain, non-steroidal anti-inflammatory drugs ...e effective than acetaminophen. , That,s the concl...SAIDs are "slightly effective" for short-term symp...
Other Medicine News:Health News:Your personality type influences how much self-control you have 2Health News:Z Trim Holdings, Inc. Launches Innovative Retail Line of Lower Fat Salad Dressings in Upscale Grocery Chain 2Health News:Z Trim Holdings, Inc. Launches Innovative Retail Line of Lower Fat Salad Dressings in Upscale Grocery Chain 3Health News:'Military Spouse of the Year 2008' Announced 2Health News:Genetics May Determine Antidepressants' Effectiveness 2Health News:What gives us fingertip dexterity? 2Health News:What gives us fingertip dexterity? 3Health News:NSAIDs No Better for Low Back Pain 2
(Date:12/4/2009)INDIANAPOLIS, Dec. 4 The U.S. Food and Drug Administration (FDA) today approved Zyprexa® (olanzapine) in tablet form as an option for the treatment of schizophrenia and manic or mixed episodes
(Date:12/4/2009)Workers Ensure Emergency Deliveries are Transported ,, PHILADELPHIA, Dec. 4 Teamster members employed by the Philadelphia chapter of the American Red Cross are hard at work educating the public abo
(Date:12/4/2009)DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that the first patient has been enrolled in the company,s Phase II-b, dose escalation, clinical trial in S
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 1Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 2Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 3Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 4Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 5Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 6Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 7Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 8Gene Mutation Could Be Key to Rare Blood Vessel Disease 52456 1Gene Mutation Could Be Key to Rare Blood Vessel Disease 52456 2Gene Mutation Could Be Key to Rare Blood Vessel Disease 52456 3Global One Consulting Announces Exclusive Contract to Expand Saigene Biotech Inc Sales in Emerging Markets 13155 1Global One Consulting Announces Exclusive Contract to Expand Saigene Biotech Inc Sales in Emerging Markets 13155 2Global One Consulting Announces Exclusive Contract to Expand Saigene Biotech Inc Sales in Emerging Markets 13155 3
...d Muscle Society International Congress, SOUTH PL...TC), a biopharmaceutical company focused on the di...l-molecule drugs targeting,post-transcriptional co...from a Phase 2 clinical trial of PTC124 in patient...nonsense mutation. The results, which include data...
... Trial Results of First Pro-Healing Stent Also ...ONG KONG, Oct. 18 OrbusNeich,s Genous(TM),Bio-eng...ions about,innovation in interventional cardiology...catheter Cardiovascular Therapeutics symposium, TC...on Convention Center in,Washington, D.C. The line...
Other Medicine Technology:PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 2PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 3PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 4OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Subject of Sessions on Innovation at TCT 2007 2
... allows the physician to intubate the canaliculi i...anesthetic drops., ,The SRS is made of medical...25mm, 30mm and 35mm (disposable sizers sold separa...d head to provide fixation. Each head consists of ...
...s a peptide highly dependent on growth hormone and...ansported in serum by several IGF-binding proteins...ts of IGF-I are a useful adjunct to assessment of ... IGF-I concentration is strong evidence against GH...
...ystem built around the many positive attributes ,...of Logic Driven Incubation (LDI). LDI technology ,...ance with the fastest possible incubation times. ,...iac biomarkers and HCG to be run in around 15 ,m...
ACS:180 C-Peptide Assay
Medicine Products: